Navigation Links
EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
Date:5/21/2014

St Jude Medical's Nanostim device and Medtronic's Micra, both single-chamber leadless pacing systems, and the most advanced commercially available valve, the Edwards Sapien 3 Transcatheter Heart Valve (Edwards Life Sciences) featured in the discussions.

With regard to leadless pacing, participants heard that there was a need for a novel system that provides reliable pacing and sensing, and addresses the challenges of current pacing systems by minimising the risks of infection, pneumothorax, dislodgement and long-term infection.

Prof Panos Vardas, University Hospital of Crete, Greece, President of the ESC and a past President of EHRA, said: "The two different technologies, leadless pacemakers and the new generation valves, reflect the progress seen within interventional cardiology and electrophysiology. In the case of the leadless pacemaker, advances in the longevity of the battery of the devices, which are now expected to last seven to ten years, have been a most important advancement."

Prof Karl Heinz Kuck, St George hospital, Hamburg, Germany, and President of EHRA, then commented on a video demonstrating the implantation of the leadless technology and informed delegates about the status of the early clinical evidence in the field of leadless pacing.

Kuck said: "The technical advancement with leadless pacemakers represents 'a big step forward'. These devices have the advantage of a reduced risk of infection and also a significantly lower risk of thromboembolic complications that may lead to pulmonary hypertension. The only uncertainties that we currently face are due to the fact that the experience with the device is still rather limited, and we are yet to identify the best position to have a safe implantation. My personal view is that we need better imaging technology during the implant to guarantee that the device goes to the septum and not to the free wall," Kuck said.

Vardas added, "Leadless pacing is a very significant development, but to take it from the current VVIR configuration to the next stage of double-chamber pacing is going to be a challenge. Also, we need longer follow-up, and a better understanding of the thrombogenicity of the devices and possible complications, but I am optimistic that progress is underway."

Trancatheter aortic heart valve developments

Participants also saw an interactive live transmission from Prof Stephan Windecker and team, from Bern University Hospital, Bern, Switzerland, of a complete implantation of the Edwards Sapien 3 valve in approximately 40 minutes. The expert panel noted that advancements in valve technology had significantly impacted the incidence of severe paravalvular leak with no reported cases of severe leak with these devices.


'/>"/>

Contact: Isabelle Uzielli
iuzielli@europcr.com
EuroPCR
Source:Eurekalert

Related medicine news :

1. CRF will Provide updates on several key cardiovascular trials at EuroPCR
2. New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014
3. Joseph Sorbara Showcases Exquisite Beginner Level Recipes in his Latest Paleo Recipe Book
4. MessageSolution Showcases IBM SmartCloud Integration and Award Winning Archiving Solutions at IBM Connect 2013
5. AvePoint Showcases Compliance Solutions as Gold Sponsor of the IAPP Global Privacy Summit in Washington, DC
6. Amirsys Showcases Radiology Products at European Congress of Radiology
7. AvePoint Showcases Enterprise Collaboration Solutions as Title Sponsor of SharePoint Fest Denver 2013
8. Tanimura & Antle Showcases Salinas Valley Produce at Pebble Beach Culinary Event
9. KillerApps.TV Technology and Trends Expert Brett Larson Showcases the Latest Gadgets and Trending Gift Ideas for Mother’s Day 2013
10. ANT Wireless Showcases Ease of Wireless Energy Management Systems and Interoperable ANT+ Sport, Fitness and Health Monitoring Products at Wireless Japan
11. MessageSolution Showcases its Newly Released Enterprise Archive and eDiscovery Platform 7.0 at Tech Expo, Supporting Microsoft Exchange and SharePoint 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... RANKED Health , a program to critically evaluate and rank health-focused applications ... the program is to provide independent, unbiased and accurate information to help accelerate ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... and CEO of EMED, today signed a multifaceted agreement which will allow for ... Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and Nursing ...
(Date:4/30/2016)... ... , ... well is a challenge for all of us, but there are things we can do to ... “Research is showing more and more that there are simple, yet important steps that can ... age.” Top priorities Dr. Kohli’s recommends for her patients include;, , exercise ...
(Date:4/29/2016)... , ... April 30, 2016 , ... ... of patented products, announces the Pick Up Springboard, an automotive invention that improves ... Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published April 16th ... for Botox and lip injections, which she underwent in order to feel more at ... and Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; many ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: